PeerVoice Endocrinology & Metabolic Disorders Audio

PeerVoice
PeerVoice Endocrinology & Metabolic Disorders Audio

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

  1. 19 DIC

    Gideon Hirschfield, MB BChir, FRCP, PhD - Keeping Pace With the Latest in PBC: Practical Perspectives on What’s New and What’s Next

    Visit https://www.peervoice.com/BYM860 to view the entire programme with slides. After completing “Gideon Hirschfield, MB BChir, FRCP, PhD - Keeping Pace With the Latest in PBC: Practical Perspectives on What’s New and What’s Next”, participants will be able to: Differentiate between available and emerging therapies for the treatment of primary biliary cholangitis (PBC); Evaluate available efficacy and safety data for emerging therapies for the treatment of PBC; and Define key practical steps in the identification of patients who may benefit from additional lines of treatment for PBC.

    31 min

  2. 19 DIC

    Olga Kordonouri, MD - Confronting the Silent Progression of Type 1 Diabetes: Rationales and Roadmaps for Early Detection and Proactive Intervention

    Visit https://www.peervoice.com/GTU860 to view the entire programme with slides. After completing “Olga Kordonouri, MD - Confronting the Silent Progression of Type 1 Diabetes: Rationales and Roadmaps for Early Detection and Proactive Intervention”, participants will be able to: Explain the rationale for conducting autoantibody screening for presymptomatic type 1 diabetes (T1D); Identify current recommendations and practical considerations for conducting autoantibody screening for T1D; Use the results of autoantibody screening for T1D to inform education, monitoring, follow-up, and management plans for individual patients; and Evaluate the mechanisms of, available efficacy and safety data for, and practical considerations related to novel therapies targeting the underlying pathogenesis of T1D.

    53 min

  3. 17 DIC

    Ian SD Roberts, MBChB, FRCPath / Joris Roelofs, MD, PhD - Best Practices in Renal Pathology: Avoiding Common Pitfalls in the Diagnostic Pathways for Glomerular Diseases

    Visit https://www.peervoice.com/RAB860 to view the entire programme with slides. After completing “Ian SD Roberts, MBChB, FRCPath / Joris Roelofs, MD, PhD - Best Practices in Renal Pathology: Avoiding Common Pitfalls in the Diagnostic Pathways for Glomerular Diseases”, participants will be able to: Identify the importance of histopathologic findings in differentiating between specific glomerular diseases; Apply best practices in the preparation and evaluation of renal biopsies for specific glomerular diseases such as complement 3 glomerulopathy (C3G), immune complex-mediated membranoproliferative glomerulonephritis (IC-MPGN), and immunoglobulin A nephropathy (IgAN); Propose practical strategies for communication and reporting which facilitate collaboration between nephropathologists and nephrologists to achieve clinical-pathologic correlation and definitive diagnosis of specific glomerular diseases; and Evaluate novel processes for, and benefits of, digitisation and archiving of renal biopsy samples.

    39 min

  4. 13 DIC

    Kris V. Kowdley, MD - Navigating Cases of PBC Alongside the Experts: Best Practices in Tracking Treatment Response and Targeting Contemporary Goals of Care

    Visit https://www.peervoice.com/DNW860 to view the entire programme with slides. After completing “Kris V. Kowdley, MD - Navigating Cases of PBC Alongside the Experts: Best Practices in Tracking Treatment Response and Targeting Contemporary Goals of Care”, participants will be able to: Propose goals of treatment in primary biliary cholangitis (PBC) related to both disease and symptom control; Apply recommended approaches to evaluate patient response to, and tolerance of, first-line treatment for PBC; and Identify patients who may benefit from second-line treatments for PBC.

    32 min

  5. 15 NOV

    Jonathan Barratt, PhD, FRCP / Joris Roelofs, MD, PhD - The Central Role of Renal Pathology in the Differential Diagnosis of Glomerular Diseases: Sharing Expertise, Experience, and Essential Next Steps

    Visit https://www.peervoice.com/NAU860 to view the entire programme with slides. After completing “Jonathan Barratt, PhD, FRCP / Joris Roelofs, MD, PhD - The Central Role of Renal Pathology in the Differential Diagnosis of Glomerular Diseases: Sharing Expertise, Experience, and Essential Next Steps”, participants will be able to: Explain the pathophysiologic pathways underlying the development of rare kidney diseases, including glomerular diseases such as complement 3 glomerulopathy (C3G), immune complex-mediated membranoproliferative glomerulonephritis (IC-MPGN), and immunoglobulin A nephropathy (IgAN); Identify best practices in the evaluation of renal biopsies in the setting of suspected glomerular diseases, including C3G, IC-MPGN, and IgAN; and Design diagnostic workflows for glomerular diseases which facilitate communication and collaboration between nephrologists and nephropathologists to promote definitive diagnosis.

    20 min

  6. 25 OCT

    Angela Fitch, MD, FACP, MFOMA - This Cannot Weight: A Specialist Guide to Weight Management and Obesity Associated With Emotional Eating Behaviours

    Visit https://www.peervoice.com/VYS860 to view the entire programme with slides. After completing “Angela Fitch, MD, FACP, MFOMA - This Cannot Weight: A Specialist Guide to Weight Management and Obesity Associated With Emotional Eating Behaviours”, participants will be able to: Describe the current patient- and healthcare-associated barriers to accessing obesity management therapy; Summarise the obesity phenotypes including hedonic eating behaviours and their role within the understanding of obesity management; Outline the role and clinical evidence for current therapies used as part of weight management strategies across obesity phenotypes; and Apply evidence-based therapeutic strategies to individualise care in patients with obesity associated with emotional eating.

    20 min

  7. 25 OCT

    Jonathan Barratt, PhD, FRCP - Redefining Hope: The IgA Nephropathy Journey

    Visit https://www.peervoice.com/GPM860 to view the entire programme with slides. After completing “Jonathan Barratt, PhD, FRCP - Redefining Hope: The IgA Nephropathy Journey”, participants will be able to: Summarize the patient perspective of disease burden and unmet needs in the management of immunoglobulin A nephropathy (IgAN); Recognize the clinical significance of established clinical trial endpoints including estimated glomerular filtration rate (eGFR); and Conceptualize the current and emerging therapeutic developments in terms of the challenges they aim to address in the management of IgAN.

    21 min

  8. 21 MAY

    Maria Craig, MBBS, PhD, FRACP, MMed(ClinEpid) - Treating T2D in People of Younger Age in This Day and Age: How Would You Manage These Children and Adolescents With T2D?

    Visit https://www.peervoice.com/GBR860 to view the entire programme with slides. After completing “Maria Craig, MBBS, PhD, FRACP, MMed(ClinEpid) - Treating T2D in People of Younger Age in This Day and Age: How Would You Manage These Children and Adolescents With T2D?”, participants will be able to: Evaluate the efficacy and safety evidence for recommended interventions to manage type 2 diabetes (T2D) in children and adolescents; Describe age-, disease-, and treatment-related considerations which impact decision-making in the treatment of T2D in children and adolescents; and Propose evidence-based, guideline-recommended management plans for children and adolescents with T2D.

    47 min
Ver todo (40)

Calificaciones y reseñas

3.2
de 5
6 calificaciones

Acerca de

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Información

Más de PeerVoice

También te podría interesar

Para escuchar episodios explícitos, inicia sesión.

Mantente al día con este programa

Inicia sesión o regístrate para seguir programas, guardar episodios y enterarte de las últimas novedades.
Elige un país o región

Africa, Oriente Medio e India

Asia-Pacífico

Europa

Latinoamérica y el Caribe

Estados Unidos y Canadá